Trending Now
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...
Ocugen Inc (NASDAQ: OCGN) is pleased to unveil the positive outcomes of a recent Covid-19 Vaccine trial. The study focused on children aged 2-18...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Apellis Pharmaceuticals Inc (NASDAQ:APLS) Reveals 18-month data From Its Phase 1b...
Apellis Pharmaceuticals Inc (NASDAQ:APLS) recently 18 months’ worth of data collected through its Phase 1b APL2-103 study evaluating pegcetacoplan as a treatment for advanced...
MAKE IT MODERN
LATEST REVIEWS
BioNTech (NASDAQ:BNTX) And Pfizer Inc. (NYSE:PFE) Announce Commencement Of EMA Rolling...
BioNTech (NASDAQ:BNTX) and Pfizer Inc. (NYSE:PFE) have announced that the European Medicines Agency (EMA) has commenced a rolling review for their leading COVID-19 vaccine...
MAKE IT MODERN
PERFORMANCE TRAINING
Are the recent gains on Longeveron Inc (NASDAQ: LGVN) sustainable ?
In recent times, Longeveron Inc. (NASDAQ: LGVN) has been at the forefront of biotechnological innovation, particularly in addressing Hypoplastic Left Heart Syndrome...
Black Diamond Therapeutics Inc (NASDAQ:BDTX) Surges on Market Optimism
In the rapidly evolving landscape of healthcare and medicine, precision oncology stands out as a beacon of hope for individuals diagnosed...
ENDRA Life Sciences (NASDAQ: NDRA) Announces $8 Million Public Offering, Fuels Future Growth
Yesterday, ENDRA Life Sciences Inc. (Nasdaq: NDRA), a pioneer in Thermo Acoustic Enhanced Ultrasound (TAEUS®), officially announced the pricing of its public...
The FDA Grants Ocugen Inc. (NASDAQ:OCGN) the Fourth Orphan Drug Designation (ODD) for OCU400...
Ocugen Inc. (NASDAQ:OCGN) is one of the forces to reckon in the development of innovative eye therapeutics. The company’s product lines aim to therapy...
Could AppTech Payments Corp (NASDAQ:APCX) Dominate All Digital Payments ?
With all the financial technology out there, why is moving money from person to person, business to business, or paying for goods...
MAKE IT MODERN
